Adults (ages 15+) living with HIV in Portugal
Portugal: Adults (ages 15+) living with HIV was 50,000 in 2024. ▲ Rising
Adults (ages 15+) living with HIV in Portugal, 1990–2024
Source: UNAIDS estimates.
Analysis
The most recent figure for adults (ages 15+) living with hiv in Portugal is 50,000, measured in 2024. That is the highest value across all 35 years on record.
The figure is up 2.0% on the previous year and up 19.0% over ten years.
Over the whole period, adults (ages 15+) living with hiv in Portugal peaked at 50,000 in 2024 and was at its lowest, 13,000, in 1990.
That places Portugal 58th out of 151 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 35 years of available data.
Adults (ages 15+) living with HIV in Portugal, year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 13,000 | — |
| 1991 | 15,000 | +15.4% |
| 1992 | 18,000 | +20.0% |
| 1993 | 20,000 | +11.1% |
| 1994 | 22,000 | +10.0% |
| 1995 | 24,000 | +9.1% |
| 1996 | 25,000 | +4.2% |
| 1997 | 27,000 | +8.0% |
| 1998 | 28,000 | +3.7% |
| 1999 | 29,000 | +3.6% |
| 2000 | 31,000 | +6.9% |
| 2001 | 32,000 | +3.2% |
| 2002 | 33,000 | +3.1% |
| 2003 | 34,000 | +3.0% |
| 2004 | 35,000 | +2.9% |
| 2005 | 36,000 | +2.9% |
| 2006 | 37,000 | +2.8% |
| 2007 | 38,000 | +2.7% |
| 2008 | 38,000 | +0.0% |
| 2009 | 39,000 | +2.6% |
| 2010 | 40,000 | +2.6% |
| 2011 | 40,000 | +0.0% |
| 2012 | 41,000 | +2.5% |
| 2013 | 41,000 | +0.0% |
| 2014 | 42,000 | +2.4% |
| 2015 | 42,000 | +0.0% |
| 2016 | 43,000 | +2.4% |
| 2017 | 44,000 | +2.3% |
| 2018 | 44,000 | +0.0% |
| 2019 | 45,000 | +2.3% |
| 2020 | 46,000 | +2.2% |
| 2021 | 47,000 | +2.2% |
| 2022 | 48,000 | +2.1% |
| 2023 | 49,000 | +2.1% |
| 2024 | 50,000 | +2.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 22,100 | 13,000 | 29,000 | 10 |
| 2000s | 35,300 | 31,000 | 39,000 | 10 |
| 2010s | 42,200 | 40,000 | 45,000 | 10 |
| 2020s | 48,000 | 46,000 | 50,000 | 5 |
Countries ranked near Portugal
More health data for Portugal
- Un projection of annual infant deaths, annual growth rate -2.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1616 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,112 deaths per 1,000 people (2090)
- Number of infants who die before age 1 38 deaths (2100)
- Population ages 65-69, male, annual growth rate 1.78 % change on previous year (2025)
- Population ages 65-69, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65-69, male, per capita 0.0301 units per person (2025)
- Population ages 70-74, female, annual growth rate 2.06 % change on previous year (2025)
- Population ages 70-74, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, female, per capita 0.0327 units per person (2025)
Frequently asked questions
- What is adults (ages 15+) living with hiv in Portugal?
- Adults (ages 15+) living with hiv in Portugal was 50,000 in 2024, according to UNAIDS estimates.
- What is the highest adults (ages 15+) living with hiv recorded in Portugal?
- The highest recorded value was 50,000 in 2024.
- What is the lowest adults (ages 15+) living with hiv recorded in Portugal?
- The lowest recorded value was 13,000 in 1990.
- How does Portugal rank for adults (ages 15+) living with hiv?
- Portugal ranks 58th out of 151 countries with data for 2024.
- Is adults (ages 15+) living with hiv rising or falling in Portugal?
- Over the last ten years it is up 19.0%. The long-run trend across the full record is rising.
- Where does this Portugal data come from?
- The figures come from UNAIDS estimates, published as part of Adults (ages 15+) living with HIV. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Adults living with HIV refers to the number of people ages 15-49 who are infected with HIV.